Treatment of sarcopenia and glucose intolerance through mitochondrial activation by 5-aminolevulinic acid.
Fujii C, Miyashita K, Mitsuishi M, Sato M, Fujii K, Inoue H, Hagiwara A, Endo S, Uto A, Ryuzaki M, Nakajima M, Tanaka T, Tamaki M, Muraki A, Kawai T, Itoh H.
Fujii C, et al. Among authors: uto a.
Sci Rep. 2017 Jun 21;7(1):4013. doi: 10.1038/s41598-017-03917-0.
Sci Rep. 2017.
PMID: 28638045
Free PMC article.